New RA drug ARD-885 enters first human safety tests
NCT ID NCT07266207
First seen Dec 11, 2025 · Last updated May 23, 2026 · Updated 17 times
Summary
This early-stage study tested a new drug called ARD-885 in 94 healthy volunteers and people with rheumatoid arthritis. The main goal was to see if the drug is safe and how the body processes it, including the effect of food. This is a first step to find the right dose for future larger studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS (RA) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
The Second Affiliated Hospital of Anhui Medical University
Hefei, Guangdong, China
Conditions
Explore the condition pages connected to this study.